Cancer genome sequencing studies have identified frequent gain of function mutations in the KEAP1/NRF2 pathway in human non-small cell lung carcinoma (NSCLC) (La Fleur et al., 2019). This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.